iSAM Funds (UK)’s Regeneron Pharmaceuticals REGN Stock Holding History

iSAM Funds (UK)’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-375	Closed	-$289K	–	425
2025 Q4	$289K	Buy	+375	New	+$255K	0.1%	233
2025 Q3	–	Sell	-2,539	Closed	-$1.33M	–	786
2025 Q2	$1.33M	Buy	+2,539	New	+$1.42M	0.29%	121
2025 Q1	–	Sell	-323	Closed	-$230K	–	410
2024 Q4	$230K	Sell	323 -126	-28%	-$106K	0.17%	217
2024 Q3	$472K	Buy	+449	New	+$500K	0.27%	147
2024 Q1	–	Sell	-1,006	Closed	-$884K	–	338
2023 Q4	$884K	Buy	+1,006	New	+$828K	0.63%	57

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

iSAM Funds (UK)'s REGN Position: Q1 2026 in Review

iSAM Funds (UK) sold out of Regeneron Pharmaceuticals (REGN) in Q1 2026, closing a stake of 375 shares — an estimated $289K sold.

iSAM Funds (UK) first reported a position in REGN in Q4 2023 and held it in 5 quarters. The position peaked at $1.33M in Q2 2025. 1,400 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

iSAM Funds (UK) reported no remaining Regeneron Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
iSAM Funds (UK) sold 375 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $289K.
iSAM Funds (UK) first reported a position in Regeneron Pharmaceuticals in Q4 2023 and held it in 5 quarters.
iSAM Funds (UK)'s Regeneron Pharmaceuticals position peaked at $1.33M in Q2 2025.
1,400 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on iSAM Funds (UK)'s 13F filing for Q1 2026, filed 13 May 2026.